Akoya Biosciences, Inc.
AKYA
$1.16
$0.021.75%
NASDAQ
| 03/31/2025 | 12/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -22.04% | 13.45% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -22.04% | 13.45% | |||
| Cost of Revenue | -2.69% | -1.90% | |||
| Gross Profit | -31.40% | 22.73% | |||
| SG&A Expenses | 12.06% | 6.92% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 10.46% | 3.19% | |||
| Operating Income | -131.60% | 22.82% | |||
| Income Before Tax | -90.13% | 21.76% | |||
| Income Tax Expenses | 700.00% | -118.18% | |||
| Earnings from Continuing Operations | -90.90% | 22.16% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -90.90% | 22.16% | |||
| EBIT | -131.60% | 22.82% | |||
| EBITDA | -195.87% | 30.75% | |||
| EPS Basic | -90.57% | 22.27% | |||
| Normalized Basic EPS | -56.10% | -3.23% | |||
| EPS Diluted | -90.57% | 22.27% | |||
| Normalized Diluted EPS | -56.10% | -3.23% | |||
| Average Basic Shares Outstanding | 0.21% | 0.11% | |||
| Average Diluted Shares Outstanding | 0.21% | 0.11% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||